Aerocare DME Supplier - Oxygen Equipment & Supplies Location: 915 Interstate Ridge Dr, Gainesville, Georgia 30501 Phone: (770) 535-1995 |
Walmart Pharmacy 10-0510 Durable Medical Equipment & Medical Supplies Location: 400 Shallowford Rd Nw, Gainesville, Georgia 30504 Phone: (770) 531-0325 |
Walmart Pharmacy 10-2699 Durable Medical Equipment & Medical Supplies Location: 1435 Thompson Bridge Road, Gainesville, Georgia 30501 Phone: (678) 971-6389 |
Walmart Pharmacy 10-2731 Durable Medical Equipment & Medical Supplies Location: 2892 Browns Bridge Road, Gainesville, Georgia 30504 Phone: (678) 971-6368 |
Walgreens #18189 Durable Medical Equipment & Medical Supplies Location: 2925 Browns Bridge Rd, Gainesville, Georgia 30504 Phone: (770) 532-2266 |
Walgreens #18288 Durable Medical Equipment & Medical Supplies Location: 3320 Thompson Bridge Rd, Gainesville, Georgia 30506 Phone: (770) 287-8361 |
Walgreens #6374 Durable Medical Equipment & Medical Supplies Location: 649 Shallowford Rd Nw, Gainesville, Georgia 30504 Phone: (678) 450-8847 |
Walgreens #9155 Durable Medical Equipment & Medical Supplies Location: 3414 Mundy Mill Rd, Gainesville, Georgia 30507 Phone: (770) 287-8359 |
Walgreens #9706 Durable Medical Equipment & Medical Supplies Location: 472 S Enota Dr Ne, Gainesville, Georgia 30501 Phone: (770) 535-3750 |
Watkins Total Healthcare Llc Medicare Supplier Location: 961 Green Street Ne, Gainesville, Georgia 30501 Phone: (770) 534-0656 |
News Archive
Below are comments from Len Lichtenfeld, MD, American Cancer Society deputy chief medical officer, in response to the results of the STAR trial.
Optivia Biotechnology, a leading provider of in vitro transporter assay services, today announced that the company and the U.S. Food and Drug Administration have signed a collaboration agreement to assess the effect of dietary supplements on key drug transporters.
The joint replacement market in South Africa is set to experience continued growth in the medium to long term, driven by an ageing population that is prone to cartilage degeneration and bone fractures. The introduction of innovative products with enhanced durability and longevity as well as safer operation techniques is further boosting growth in this market.
CSL Biotherapies has announced the initiation of the company's first U.S. clinical trials of its candidate Influenza A/H1N1 2009 vaccine. Study investigators will administer vaccinations to the first U.S. study volunteers today, August 24. The studies will determine the safety of CSL's candidate vaccine and its ability to elicit an immune response (also referred to as immunogenicity) in adults and children.
› Verified 4 days ago